Tabatabaei-Panah AS,Jeddi-Tehrani M,Ghods R,et al.Accurate sensitivity of quantum dots for detection of HER2expression in breast cancer cells and tissues[J].J Fluoresc,2013,23(2):293-302.
Wang Y,Chen L.Quantum dots,lighting up the research and development of nanomedicine[J].Nanomedicine,2011,7(4):385-402.
[4]
He X,Gao J,Gambhir SS,et al.Near-infrared fluorescent nanoprobes for cancer molecular imaging:status and challenges[J].Trends Mol Med,2010,16(12):574-583.
[5]
Chen C,Peng J,Xia HS,et al.Quantum dots-based immunofluorescence technology for the quantitative determination of HER2expression in breast cancer[J].Biomaterials,2009,30(15):2 912-2 918.
[6]
Chen C,Peng J,Xia H,et al.Quantum-dot-based immunofluorescent imaging of HER2 and ER provides new insights into breast cancer heterogeneity[J].Nanotechnology,2010,21(9):095101.
[7]
Liu XL,Peng CW,Chen C,et al.Quantum dotsbased double-color imaging of HER2 positive breast cancer invasion[J].Biochem Biophys Res Commun,2011,409(3):577-582.
[8]
Fang M,Yuan JP,Peng CW,et al.Quantum dotsbased in situ molecular imaging of dynamic changes of collagenⅣduring cancer invasion[J].Biomaterials,2013,34(34):8 708-8 717.
[9]
Alam F,Yadav N.Potential applications of quantum dots in mapping sentinel lymph node and detection of micrometastases in breast carcinoma[J].J Breast Cancer,2013,16(1):1-11.
[10]
Jemal A,Bray F,Center MM,et al.Global cancer statistics[J].CA Cancer J Clin,2011,61(2):69-90.
[11]
Veronesi U,Zurrida S,Goldhirsch A,et al.Breast cancer classification:time for a change[J].J Clin Oncol,2009,27(15):2 427-2 428.
[12]
Wang X,Yang L,Chen ZG,et al.Application of nanotechnology in cancer therapy and imaging[J].CA Cancer J Clin,2008,58(2):97-110.
[13]
Kosaka N,McCann TE,Mitsunaga M,et al.Real-time optical imaging using quantum dot and related nanocrystals[J].Nanomedicine(Lond),2010,5(5):765-776.
[14]
Chen C,Sun SR,Gong YP,et al.Quantum dotsbased molecular classification of breast cancer by quantitative spectroanalysis of hormone receptors and HER2[J].Biomaterials,2011,32(30):7 592-7 599.
[15]
Helle M,Cassette E,Bezdetnaya L,et al.Visualisation of sentinel lymph node with indium-based near infrared emitting Quantum Dots in a murine metastatic breast cancer model[J].PLoS One,2012,7(8):e44 433.
Soenen SJ,Manshian BB,Aubert T,et al.Cytotoxicity of cadmium-free quantum dots and their use in cell bioimaging[J].Chem Res Toxicol,2014,27(6):1 050-1 059.
[18]
Bentolila LA,Ebenstein Y,Weiss S.Quantum dots for in vivo small-animal imaging[J].J Nucl Med,2009,50(4):493-496.
[19]
Hilderbrand SA,Weissleder R.Near-infrared fluorescence:application to in vivo molecular imaging[J].Curr Opin Chem Biol,2010,14(1):71-79.
[20]
Mrklic I,Spagnoli GC,Juretic A,et al.Co-expression of cancer testis antigens and topoisomerase 2-alpha in triple negative breast carcinomas[J].Acta Histochem,2014,116(5):740-746.
[21]
Chen C,Peng J,Sun SR,et al.Tapping the potential of quantum dots for personalized oncology:current status and future perspectives[J].Nanomedicine(Lond),2012,7(3):411-428.
[22]
Garay JP,Park BH.Androgen receptor as a targeted therapy for breast cancer[J].Am J Cancer Res,2012,2(4):434-445.
[23]
Mrklic I,Capkun V,Pogorelic Z,et al.Prognostic value of Ki-67 proliferating index in triple negative breast carcinomas[J].Pathol Res Pract,2013,209(5):296-301.
[24]
Mrklic I,Pogorelic Z,Capkun V,et al.Expression of androgen receptors in triple negative breast carcinomas[J].Acta Histochem,2013,115(4):344-348.
[25]
Sugianto J,Sarode V,Peng Y.Ki-67expression is increased in p16-expressing triple-negative breast carcinoma and correlates with p16only in p53-negative tumors[J].Hum Pathol,2014,45(4):802-809.
[26]
Yang XQ,Chen C,Peng CW,et al.Quantum dotbased quantitative immunofluorescence detection and spectrum analysis of epidermal growth factor receptor in breast cancer tissue arrays[J].Int J Nanomedicine,2011,6:2 265-2 273.
[27]
Sun JZ,Chen C,Jiang G,et al.Quantum dot-based immunofluorescent imaging of Ki67and identification of prognostic value in HER2-positive(non-luminal)breast cancer[J].Int J Nanomedicine,2014,9:1 339-1 346.
[28]
Yu J,Monaco SE,Onisko A,et al.A validation study of quantum dot multispectral imaging to evaluate hormone receptor status in ductal carcinoma in situ of the breast[J].Hum Pathol,2013,44(3):394-401.
[29]
Chen C,Xia HS,Gong YP,et al.The quantitative detection of total HER2load by quantum dots and the identification of a new subtype of breast cancer with different 5-year prognosis[J].Biomaterials,2010,31(33):8 818-8 825.
[30]
Zrazhevskiy P,Sena M,Gao X.Designing multifunctional quantum dots for bioimaging,detection,and drug delivery[J].Chem Soc Rev,2010,39(11):4 326-4 354.
[31]
Pierceall WE,Sprott KM,Heikkinen T,et al.Utilization of fluorescence in situ hybridization with cytokeratin discriminators in TOP2Aassessment of chemotherapy-treated patients with breast cancer[J].Hum Pathol,2012,43(9):1 363-1 375.
[32]
Shapira I,Lee A,Vora R,et al.P53mutations in triple negative breast cancer upregulate endosomal recycling of epidermal growth factor receptor(EGFR)increasing its oncogenic potency[J].Crit Rev Oncol Hematol,2013,88(2):284-292.
[33]
Lakis S,Kotoula V,Eleftheraki AG,et al.The androgen receptor as a surrogate marker for molecular apocrine breast cancer subtyping[J].Breast,2014,23(3):234-243.
[34]
Peng CW,Liu XL,Chen C,et al.Patterns of cancer invasion revealed by QDs-based quantitative multiplexed imaging of tumor microenvironment[J].Biomaterials,2011,32(11):2 907-2 917.
[35]
Sun H,Yang B,Cui E,et al.Spectroscopic investigations on the effect of N-Acetyl-l-cysteine-Capped CdTe Quantum Dots on catalase[J].Spectrochim Acta A Mol Biomol Spectrosc,2014,132C:692-699.
[36]
Zrazhevskiy P,Gao X.Multifunctional quantum dots for personalized medicine[J].NANO TODAY,2009,4(5):414-428.
[37]
Yu KT,Byung JK,Eun SL.High-content quantum dot-based subtype diagnosis and classification of breast cancer patients using hypermulticolor quantitative single cell imaging cytometry[J].Nanotoday,2012,7(4):231-244.
[38]
Chen C,Yuan JP,Wei W,et al.Subtype classification for prediction of prognosis of breast cancer from a biomarker panel:correlations and indications[J].Int J Nanomedicine,2014,9:1 039-1 048.
